Accessibility: Skip TopNav
Phase 1b/2a Clinical Trial Summary
This figure profiles the evaluation of OPT-302 in combination with aflibercept for persistent central-involved diabetic macular edema.
Format
JPEG
Source
Opthea Limited
Downloads
Original
Large
Medium
Small